Global Non-Invasive Drug Delivery Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Non-Invasive Drug Delivery will have significant change from previous year. By the most conservative estimates of global Non-Invasive Drug Delivery market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Non-Invasive Drug Delivery market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Drug Delivery market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Non-Invasive Drug Delivery, covering the supply chain analysis, impact assessment to the Non-Invasive Drug Delivery market size growth rate in several scenarios, and the measures to be undertaken by Non-Invasive Drug Delivery companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Adherium Limited
PharmaJet
Capsule Technologies, Inc.
Diabeloop SA
HNS International, Inc.
Crossject S.A.
Novartis AG
Inovio Pharmaceuticals, Inc.
PenJet Corporation
Medtronic Plc.
Portal Instruments
Tandem Diabetes Care, Inc.
Sensiron AG
Teva Pharmaceuticals Industries Ltd.
ResMed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Non-Invasive Drug Delivery consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Non-Invasive Drug Delivery market by identifying its various subsegments.
Focuses on the key global Non-Invasive Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Non-Invasive Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Non-Invasive Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Non-Invasive Drug Delivery?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Non-Invasive Drug Delivery Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Drug Delivery Consumption 2015-2025
2.1.2 Non-Invasive Drug Delivery Consumption CAGR by Region
2.2 Non-Invasive Drug Delivery Segment by Type
2.2.1 Artificial Pancreas
2.2.2 Needle Free Injector
2.2.3 Digital Respiratory Devices
2.2.4 Other
2.3 Non-Invasive Drug Delivery Consumption by Type
2.3.1 Global Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
2.3.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Type (2015-2020)
2.3.3 Global Non-Invasive Drug Delivery Sale Price by Type (2015-2020)
2.4 Non-Invasive Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Non-Invasive Drug Delivery Consumption by Application
2.5.1 Global Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
2.5.2 Global Non-Invasive Drug Delivery Value and Market Share by Type (2015-2020)
2.5.3 Global Non-Invasive Drug Delivery Sale Price by Type (2015-2020)
3 Global Non-Invasive Drug Delivery by Company
3.1 Global Non-Invasive Drug Delivery Sales Market Share by Company
3.1.1 Global Non-Invasive Drug Delivery Sales by Company (2018-2020)
3.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Company (2018-2020)
3.2 Global Non-Invasive Drug Delivery Revenue Market Share by Company
3.2.1 Global Non-Invasive Drug Delivery Revenue by Company (2018-2020)
3.2.2 Global Non-Invasive Drug Delivery Revenue Market Share by Company (2018-2020)
3.3 Global Non-Invasive Drug Delivery Sale Price by Company
3.4 Global Non-Invasive Drug Delivery Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Non-Invasive Drug Delivery Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Non-Invasive Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Non-Invasive Drug Delivery by Regions
4.1 Non-Invasive Drug Delivery by Regions
4.2 Americas Non-Invasive Drug Delivery Consumption Growth
4.3 APAC Non-Invasive Drug Delivery Consumption Growth
4.4 Europe Non-Invasive Drug Delivery Consumption Growth
4.5 Middle East & Africa Non-Invasive Drug Delivery Consumption Growth
5 Americas
5.1 Americas Non-Invasive Drug Delivery Consumption by Countries
5.1.1 Americas Non-Invasive Drug Delivery Consumption by Countries (2015-2020)
5.1.2 Americas Non-Invasive Drug Delivery Value by Countries (2015-2020)
5.2 Americas Non-Invasive Drug Delivery Consumption by Type
5.3 Americas Non-Invasive Drug Delivery Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Non-Invasive Drug Delivery Consumption by Regions
6.1.1 APAC Non-Invasive Drug Delivery Consumption by Regions (2015-2020)
6.1.2 APAC Non-Invasive Drug Delivery Value by Regions (2015-2020)
6.2 APAC Non-Invasive Drug Delivery Consumption by Type
6.3 APAC Non-Invasive Drug Delivery Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Non-Invasive Drug Delivery by Countries
7.1.1 Europe Non-Invasive Drug Delivery Consumption by Countries (2015-2020)
7.1.2 Europe Non-Invasive Drug Delivery Value by Countries (2015-2020)
7.2 Europe Non-Invasive Drug Delivery Consumption by Type
7.3 Europe Non-Invasive Drug Delivery Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Drug Delivery by Countries
8.1.1 Middle East & Africa Non-Invasive Drug Delivery Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Non-Invasive Drug Delivery Value by Countries (2015-2020)
8.2 Middle East & Africa Non-Invasive Drug Delivery Consumption by Type
8.3 Middle East & Africa Non-Invasive Drug Delivery Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Non-Invasive Drug Delivery Distributors
10.3 Non-Invasive Drug Delivery Customer
11 Global Non-Invasive Drug Delivery Market Forecast
11.1 Global Non-Invasive Drug Delivery Consumption Forecast (2021-2025)
11.2 Global Non-Invasive Drug Delivery Forecast by Regions
11.2.1 Global Non-Invasive Drug Delivery Forecast by Regions (2021-2025)
11.2.2 Global Non-Invasive Drug Delivery Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Non-Invasive Drug Delivery Forecast by Type
11.8 Global Non-Invasive Drug Delivery Forecast by Application
12 Key Players Analysis
12.1 Adherium Limited
12.1.1 Company Information
12.1.2 Non-Invasive Drug Delivery Product Offered
12.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Adherium Limited Latest Developments
12.2 PharmaJet
12.2.1 Company Information
12.2.2 Non-Invasive Drug Delivery Product Offered
12.2.3 PharmaJet Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 PharmaJet Latest Developments
12.3 Capsule Technologies, Inc.
12.3.1 Company Information
12.3.2 Non-Invasive Drug Delivery Product Offered
12.3.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Capsule Technologies, Inc. Latest Developments
12.4 Diabeloop SA
12.4.1 Company Information
12.4.2 Non-Invasive Drug Delivery Product Offered
12.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Diabeloop SA Latest Developments
12.5 HNS International, Inc.
12.5.1 Company Information
12.5.2 Non-Invasive Drug Delivery Product Offered
12.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 HNS International, Inc. Latest Developments
12.6 Crossject S.A.
12.6.1 Company Information
12.6.2 Non-Invasive Drug Delivery Product Offered
12.6.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Crossject S.A. Latest Developments
12.7 Novartis AG
12.7.1 Company Information
12.7.2 Non-Invasive Drug Delivery Product Offered
12.7.3 Novartis AG Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Novartis AG Latest Developments
12.8 Inovio Pharmaceuticals, Inc.
12.8.1 Company Information
12.8.2 Non-Invasive Drug Delivery Product Offered
12.8.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Inovio Pharmaceuticals, Inc. Latest Developments
12.9 PenJet Corporation
12.9.1 Company Information
12.9.2 Non-Invasive Drug Delivery Product Offered
12.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 PenJet Corporation Latest Developments
12.10 Medtronic Plc.
12.10.1 Company Information
12.10.2 Non-Invasive Drug Delivery Product Offered
12.10.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Medtronic Plc. Latest Developments
12.11 Portal Instruments
12.11.1 Company Information
12.11.2 Non-Invasive Drug Delivery Product Offered
12.11.3 Portal Instruments Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Portal Instruments Latest Developments
12.12 Tandem Diabetes Care, Inc.
12.12.1 Company Information
12.12.2 Non-Invasive Drug Delivery Product Offered
12.12.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Tandem Diabetes Care, Inc. Latest Developments
12.13 Sensiron AG
12.13.1 Company Information
12.13.2 Non-Invasive Drug Delivery Product Offered
12.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sensiron AG Latest Developments
12.14 Teva Pharmaceuticals Industries Ltd.
12.14.1 Company Information
12.14.2 Non-Invasive Drug Delivery Product Offered
12.14.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Teva Pharmaceuticals Industries Ltd. Latest Developments
12.15 ResMed
12.15.1 Company Information
12.15.2 Non-Invasive Drug Delivery Product Offered
12.15.3 ResMed Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 ResMed Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Non-Invasive Drug Delivery Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Non-Invasive Drug Delivery Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Non-Invasive Drug Delivery Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Artificial Pancreas
Table 7. Major Players of Needle Free Injector
Table 8. Major Players of Digital Respiratory Devices
Table 9. Major Players of Other
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Table 12. Global Non-Invasive Drug Delivery Revenue by Type (2015-2020) ($ million)
Table 13. Global Non-Invasive Drug Delivery Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Non-Invasive Drug Delivery Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Table 17. Global Non-Invasive Drug Delivery Value by Application (2015-2020)
Table 18. Global Non-Invasive Drug Delivery Value Market Share by Application (2015-2020)
Table 19. Global Non-Invasive Drug Delivery Sale Price by Application (2015-2020)
Table 20. Global Non-Invasive Drug Delivery Sales by Company (2017-2019) (K Units)
Table 21. Global Non-Invasive Drug Delivery Sales Market Share by Company (2017-2019)
Table 22. Global Non-Invasive Drug Delivery Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Non-Invasive Drug Delivery Revenue Market Share by Company (2017-2019)
Table 24. Global Non-Invasive Drug Delivery Sale Price by Company (2017-2019)
Table 25. Global Non-Invasive Drug Delivery Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Non-Invasive Drug Delivery Products Offered
Table 27. Non-Invasive Drug Delivery Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Non-Invasive Drug Delivery Consumption by Regions 2015-2020 (K Units)
Table 29. Global Non-Invasive Drug Delivery Consumption Market Share by Regions 2015-2020
Table 30. Global Non-Invasive Drug Delivery Value by Regions 2015-2020 ($ Millions)
Table 31. Global Non-Invasive Drug Delivery Value Market Share by Regions 2015-2020
Table 32. Americas Non-Invasive Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Non-Invasive Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 34. Americas Non-Invasive Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Non-Invasive Drug Delivery Value Market Share by Countries (2015-2020)
Table 36. Americas Non-Invasive Drug Delivery Consumption by Type (2015-2020) (K Units)
Table 37. Americas Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Table 38. Americas Non-Invasive Drug Delivery Consumption by Application (2015-2020) (K Units)
Table 39. Americas Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Table 40. APAC Non-Invasive Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Non-Invasive Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 42. APAC Non-Invasive Drug Delivery Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Non-Invasive Drug Delivery Value Market Share by Regions (2015-2020)
Table 44. APAC Non-Invasive Drug Delivery Consumption by Type (2015-2020) (K Units)
Table 45. APAC Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Table 46. APAC Non-Invasive Drug Delivery Consumption by Application (2015-2020) (K Units)
Table 47. APAC Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Table 48. Europe Non-Invasive Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Non-Invasive Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 50. Europe Non-Invasive Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Non-Invasive Drug Delivery Value Market Share by Countries (2015-2020)
Table 52. Europe Non-Invasive Drug Delivery Consumption by Type (2015-2020) (K Units)
Table 53. Europe Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Table 54. Europe Non-Invasive Drug Delivery Consumption by Application (2015-2020) (K Units)
Table 55. Europe Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Non-Invasive Drug Delivery Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Non-Invasive Drug Delivery Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Non-Invasive Drug Delivery Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Non-Invasive Drug Delivery Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Non-Invasive Drug Delivery Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Table 64. Non-Invasive Drug Delivery Distributors List
Table 65. Non-Invasive Drug Delivery Customer List
Table 66. Global Non-Invasive Drug Delivery Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Non-Invasive Drug Delivery Consumption Market Forecast by Regions
Table 68. Global Non-Invasive Drug Delivery Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Non-Invasive Drug Delivery Value Market Share Forecast by Regions
Table 70. Global Non-Invasive Drug Delivery Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Non-Invasive Drug Delivery Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Non-Invasive Drug Delivery Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Non-Invasive Drug Delivery Value Market Share Forecast by Type (2021-2025)
Table 74. Global Non-Invasive Drug Delivery Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Non-Invasive Drug Delivery Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Non-Invasive Drug Delivery Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Non-Invasive Drug Delivery Value Market Share Forecast by Application (2021-2025)
Table 78. Adherium Limited Product Offered
Table 79. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Adherium Limited Main Business
Table 81. Adherium Limited Latest Developments
Table 82. Adherium Limited Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 83. PharmaJet Product Offered
Table 84. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. PharmaJet Main Business
Table 86. PharmaJet Latest Developments
Table 87. PharmaJet Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 88. Capsule Technologies, Inc. Product Offered
Table 89. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Capsule Technologies, Inc. Main Business
Table 91. Capsule Technologies, Inc. Latest Developments
Table 92. Capsule Technologies, Inc. Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 93. Diabeloop SA Product Offered
Table 94. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Diabeloop SA Main Business
Table 96. Diabeloop SA Latest Developments
Table 97. Diabeloop SA Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 98. HNS International, Inc. Product Offered
Table 99. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. HNS International, Inc. Main Business
Table 101. HNS International, Inc. Latest Developments
Table 102. HNS International, Inc. Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 103. Crossject S.A. Product Offered
Table 104. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. Crossject S.A. Main Business
Table 106. Crossject S.A. Latest Developments
Table 107. Crossject S.A. Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis AG Product Offered
Table 109. Novartis AG Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis AG Main Business
Table 111. Novartis AG Latest Developments
Table 112. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Inovio Pharmaceuticals, Inc. Product Offered
Table 114. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Inovio Pharmaceuticals, Inc. Main Business
Table 116. Inovio Pharmaceuticals, Inc. Latest Developments
Table 117. Inovio Pharmaceuticals, Inc. Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 118. PenJet Corporation Product Offered
Table 119. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 120. PenJet Corporation Main Business
Table 121. PenJet Corporation Latest Developments
Table 122. PenJet Corporation Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 123. Medtronic Plc. Product Offered
Table 124. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 125. Medtronic Plc. Main Business
Table 126. Medtronic Plc. Latest Developments
Table 127. Medtronic Plc. Basic Information, Company Total Revenue (in $ million), Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 128. Portal Instruments Product Offered
Table 129. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 130. Portal Instruments Main Business
Table 131. Portal Instruments Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Portal Instruments Latest Developments
Table 133. Tandem Diabetes Care, Inc. Product Offered
Table 134. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 135. Tandem Diabetes Care, Inc. Main Business
Table 136. Tandem Diabetes Care, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. Tandem Diabetes Care, Inc. Latest Developments
Table 138. Sensiron AG Product Offered
Table 139. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 140. Sensiron AG Main Business
Table 141. Sensiron AG Latest Developments
Table 142. Sensiron AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 143. Teva Pharmaceuticals Industries Ltd. Product Offered
Table 144. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 145. Teva Pharmaceuticals Industries Ltd. Main Business
Table 146. Teva Pharmaceuticals Industries Ltd. Latest Developments
Table 147. Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 148. ResMed Product Offered
Table 149. ResMed Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 150. ResMed Main Business
Table 151. ResMed Latest Developments
Table 152. ResMed Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Non-Invasive Drug Delivery
Figure 2. Non-Invasive Drug Delivery Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Non-Invasive Drug Delivery Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Non-Invasive Drug Delivery Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Artificial Pancreas
Figure 7. Product Picture of Needle Free Injector
Figure 8. Product Picture of Digital Respiratory Devices
Figure 9. Product Picture of Other
Figure 10. Global Non-Invasive Drug Delivery Consumption Market Share by Type (2015-2020)
Figure 11. Global Non-Invasive Drug Delivery Value Market Share by Type (2015-2020)
Figure 12. Non-Invasive Drug Delivery Consumed in Hospital
Figure 13. Global Non-Invasive Drug Delivery Market: Hospital (2015-2020) (K Units)
Figure 14. Global Non-Invasive Drug Delivery Market: Hospital (2015-2020) ($ Millions)
Figure 15. Non-Invasive Drug Delivery Consumed in Clinic
Figure 16. Global Non-Invasive Drug Delivery Market: Clinic (2015-2020) (K Units)
Figure 17. Global Non-Invasive Drug Delivery Market: Clinic (2015-2020) ($ Millions)
Figure 18. Non-Invasive Drug Delivery Consumed in Other
Figure 19. Global Non-Invasive Drug Delivery Market: Other (2015-2020) (K Units)
Figure 20. Global Non-Invasive Drug Delivery Market: Other (2015-2020) ($ Millions)
Figure 21. Global Non-Invasive Drug Delivery Consumption Market Share by Application (2015-2020)
Figure 22. Global Non-Invasive Drug Delivery Value Market Share by Application (2015-2020)
Figure 23. Global Non-Invasive Drug Delivery Sales Market Share by Company in 2017
Figure 24. Global Non-Invasive Drug Delivery Sales Market Share by Company in 2019
Figure 25. Global Non-Invasive Drug Delivery Revenue Market Share by Company in 2017
Figure 26. Global Non-Invasive Drug Delivery Revenue Market Share by Company in 2019
Figure 27. Global Non-Invasive Drug Delivery Sale Price by Company in 2019
Figure 28. Global Non-Invasive Drug Delivery Consumption Market Share by Regions 2015-2020
Figure 29. Global Non-Invasive Drug Delivery Value Market Share by Regions 2015-2020
Figure 30. Americas Non-Invasive Drug Delivery Consumption 2015-2020 (K Units)
Figure 31. Americas Non-Invasive Drug Delivery Value 2015-2020 ($ Millions)
Figure 32. APAC Non-Invasive Drug Delivery Consumption 2015-2020 (K Units)
Figure 33. APAC Non-Invasive Drug Delivery Value 2015-2020 ($ Millions)
Figure 34. Europe Non-Invasive Drug Delivery Consumption 2015-2020 (K Units)
Figure 35. Europe Non-Invasive Drug Delivery Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Non-Invasive Drug Delivery Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Non-Invasive Drug Delivery Value 2015-2020 ($ Millions)
Figure 38. Americas Non-Invasive Drug Delivery Consumption Market Share by Countries in 2019
Figure 39. Americas Non-Invasive Drug Delivery Value Market Share by Countries in 2019
Figure 40. Americas Non-Invasive Drug Delivery Consumption Market Share by Type in 2019
Figure 41. Americas Non-Invasive Drug Delivery Consumption Market Share by Application in 2019
Figure 42. United States Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 43. United States Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Non-Invasive Drug Delivery Consumption Market Share by Countries in 2019
Figure 49. APAC Non-Invasive Drug Delivery Value Market Share by Regions in 2019
Figure 50. APAC Non-Invasive Drug Delivery Consumption Market Share by Type in 2019
Figure 51. APAC Non-Invasive Drug Delivery Consumption Market Share by Application in 2019
Figure 52. China Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 53. China Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 60. India Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 61. India Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Non-Invasive Drug Delivery Consumption Market Share by Countries in 2019
Figure 65. Europe Non-Invasive Drug Delivery Value Market Share by Countries in 2019
Figure 66. Europe Non-Invasive Drug Delivery Consumption Market Share by Type in 2019
Figure 67. Europe Non-Invasive Drug Delivery Consumption Market Share by Application in 2019
Figure 68. Germany Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 70. France Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 71. France Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 72. UK Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 73. UK Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Non-Invasive Drug Delivery Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Non-Invasive Drug Delivery Consumption Market Share by Application in 2019
Figure 82. Egypt Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Non-Invasive Drug Delivery Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Non-Invasive Drug Delivery Value Growth 2015-2020 ($ Millions)
Figure 92. Global Non-Invasive Drug Delivery Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Non-Invasive Drug Delivery Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 95. Americas Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 96. APAC Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 97. APAC Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 98. Europe Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 99. Europe Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 102. United States Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 103. United States Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 104. Canada Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 105. Canada Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 106. Mexico Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 107. Mexico Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 108. Brazil Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 109. Brazil Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 110. China Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 111. China Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 112. Japan Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 113. Japan Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 114. Korea Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 115. Korea Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 118. India Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 119. India Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 120. Australia Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 121. Australia Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 122. Germany Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 123. Germany Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 124. France Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 125. France Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 126. UK Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 127. UK Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 128. Italy Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 129. Italy Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 130. Russia Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 131. Russia Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 132. Spain Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 133. Spain Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 134. Egypt Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 135. Egypt Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 136. South Africa Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 137. South Africa Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 138. Israel Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 139. Israel Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 140. Turkey Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 141. Turkey Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Non-Invasive Drug Delivery Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Non-Invasive Drug Delivery Value 2021-2025 ($ Millions)
Figure 144. Adherium Limited Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 145. PharmaJet Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 146. Capsule Technologies, Inc. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 147. Diabeloop SA Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 148. HNS International, Inc. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 149. Crossject S.A. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 150. Novartis AG Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 151. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 152. PenJet Corporation Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 153. Medtronic Plc. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 154. Portal Instruments Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 155. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 156. Sensiron AG Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 157. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Market Share (2018-2020)
Figure 158. ResMed Non-Invasive Drug Delivery Market Share (2018-2020)
